Teva Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals

TEVA 20.03

-1.1%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Lance Bredvold	2/27/2024 12:26:11 PM
	Read Replies (1) of 340

Tone of the company seems to have changed to positive rather than defensive. And since earnings have held up around $2.50 perhaps a more realistic PE ratio can be assumed. I'd made significant purchases under $9 which seem prescient at the moment with the price higher than it's been since 2019 ($13.25). If fears of further penalties has subsided, why shouldn't the price rise to a PE of at least 10? I am currently buying back quite a few $11 and $12 calls I'd sold before the stock price began to move beyond the cyclical $11 to $8 which had been happening for 5 years. Company seems to have a couple potential blockbuster branded drugs out and plans to continue also as a generic producer as well--businesses it knows well. I hope to obtain a goodly return on a couple of purchases made 5 and 6 years ago just under $20.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next